Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Sep;89(9):877–880. doi: 10.1136/adc.2003.037341

Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice

E Antonarakis 1, R Hain 1
PMCID: PMC1763197  PMID: 15321871

Full Text

The Full Text of this article is available as a PDF (63.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aksoylar S., Akman S. A., Ozgenç F., Kansoy S. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol. 2001 Sep;18(6):397–406. doi: 10.1080/088800101316922029. [DOI] [PubMed] [Google Scholar]
  2. Allen J. C., Gralla R., Reilly L., Kellick M., Young C. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol. 1985 Aug;3(8):1136–1141. doi: 10.1200/JCO.1985.3.8.1136. [DOI] [PubMed] [Google Scholar]
  3. Alvarez O., Freeman A., Bedros A., Call S. K., Volsch J., Kalbermatter O., Halverson J., Convy L., Cook L., Mick K. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol. 1995 May;17(2):145–150. doi: 10.1097/00043426-199505000-00008. [DOI] [PubMed] [Google Scholar]
  4. Basade M., Kulkarni S. S., Dhar A. K., Sastry P. S., Saikia B., Advani S. H. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy. Indian Pediatr. 1996 Apr;33(4):321–323. [PubMed] [Google Scholar]
  5. Bender Catherine M., McDaniel Roxanne W., Murphy-Ende Kathleen, Pickett Mary, Rittenberg Cynthia N., Rogers Miriam P., Schneider Susan M., Schwartz Rowena N. Chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 2002 Mar-Apr;6(2):94–102. doi: 10.1188/02.CJON.94-102. [DOI] [PubMed] [Google Scholar]
  6. Benoit Y., Hulstaert F., Vermylen C., Sariban E., Hoyoux C., Uyttebroeck A., Otten J., Laureys G., De Kerpel I., Nortier D. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy. Med Pediatr Oncol. 1995 Dec;25(6):457–462. doi: 10.1002/mpo.2950250607. [DOI] [PubMed] [Google Scholar]
  7. Brock P., Brichard B., Rechnitzer C., Langeveld N. E., Lanning M., Söderhäll S., Laurent C. An increased loading dose of ondansetron: a north european, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2. Eur J Cancer. 1996 Sep;32A(10):1744–1748. doi: 10.1016/0959-8049(96)00157-8. [DOI] [PubMed] [Google Scholar]
  8. Chan H. S., Correia J. A., MacLeod S. M. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics. 1987 Jun;79(6):946–952. [PubMed] [Google Scholar]
  9. Chawla Sant P., Grunberg Steven M., Gralla Richard J., Hesketh Paul J., Rittenberg Cindy, Elmer Mary E., Schmidt Carrie, Taylor Arlene, Carides Alexandra D., Evans Judith K. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer. 2003 May 1;97(9):2290–2300. doi: 10.1002/cncr.11320. [DOI] [PubMed] [Google Scholar]
  10. Coppes M. J., Lau R., Ingram L. C., Wiernikowski J. T., Grant R., Howard D. R., Perrotta M., Barr R., Dempsey E., Greenberg M. L. Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Med Pediatr Oncol. 1999 Aug;33(2):99–105. doi: 10.1002/(sici)1096-911x(199908)33:2<99::aid-mpo7>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  11. Coppes M. J., Yanofsky R., Pritchard S., Leclerc J. M., Howard D. R., Perrotta M., Keays S., Pyesmany A., Dempsey E., Pratt C. B. Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. J Pediatr Hematol Oncol. 1999 Jul-Aug;21(4):274–283. doi: 10.1097/00043426-199907000-00007. [DOI] [PubMed] [Google Scholar]
  12. Craft A. W., Price L., Eden O. B., Shaw P., Campbell R., Pierce D. M., Murdoch R., Upward J. Granisetron as antiemetic therapy in children with cancer. Med Pediatr Oncol. 1995 Jul;25(1):28–32. doi: 10.1002/mpo.2950250107. [DOI] [PubMed] [Google Scholar]
  13. Davies J. H., Evans B. A. J., Jenney M. E. M., Gregory J. W. In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy. Bone. 2002 Aug;31(2):319–326. doi: 10.1016/s8756-3282(02)00822-0. [DOI] [PubMed] [Google Scholar]
  14. Dick G. S., Meller S. T., Pinkerton C. R. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child. 1995 Sep;73(3):243–245. doi: 10.1136/adc.73.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dolgin M. J., Katz E. R., McGinty K., Siegel S. E. Anticipatory nausea and vomiting in pediatric cancer patients. Pediatrics. 1985 Mar;75(3):547–552. [PubMed] [Google Scholar]
  16. Dupuis L. L., Lau R., Greenberg M. L. Delayed nausea and vomiting in children receiving antineoplastics. Med Pediatr Oncol. 2001 Aug;37(2):115–121. doi: 10.1002/mpo.1179. [DOI] [PubMed] [Google Scholar]
  17. Ekert H., Waters K. D., Jurk I. H., Mobilia J., Loughnan P. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust. 1979 Dec 15;2(12):657–659. [PubMed] [Google Scholar]
  18. Foot A. B., Hayes C. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Arch Dis Child. 1994 Nov;71(5):475–480. doi: 10.1136/adc.71.5.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Graham-Pole J., Weare J., Engel S., Gardner R., Mehta P., Gross S. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine. J Clin Oncol. 1986 Jul;4(7):1110–1113. doi: 10.1200/JCO.1986.4.7.1110. [DOI] [PubMed] [Google Scholar]
  20. Hesketh P. J., Kris M. G., Grunberg S. M., Beck T., Hainsworth J. D., Harker G., Aapro M. S., Gandara D., Lindley C. M. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997 Jan;15(1):103–109. doi: 10.1200/JCO.1997.15.1.103. [DOI] [PubMed] [Google Scholar]
  21. Hesketh Paul J., Grunberg Steven M., Gralla Richard J., Warr David G., Roila Fausto, de Wit Ronald, Chawla Sant P., Carides Alexandra D., Ianus Juliana, Elmer Mary E. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group. J Clin Oncol. 2003 Oct 14;21(22):4112–4119. doi: 10.1200/JCO.2003.01.095. [DOI] [PubMed] [Google Scholar]
  22. Hirota T., Honjo T., Kuroda R., Saeki K., Katano N., Sakakibara Y., Shimizu H., Fujimoto T. [Antiemetic efficacy of granisetron in pediatric cancer treatment--(2). Comparison of granisetron and granisetron plus methylprednisolone as antiemetic prophylaxis]. Gan To Kagaku Ryoho. 1993 Dec;20(15):2369–2373. [PubMed] [Google Scholar]
  23. Hählen K., Quintana E., Pinkerton C. R., Cedar E. A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children. J Pediatr. 1995 Feb;126(2):309–313. doi: 10.1016/s0022-3476(95)70568-6. [DOI] [PubMed] [Google Scholar]
  24. Jürgens H., McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology. 1992;49(4):279–285. doi: 10.1159/000227057. [DOI] [PubMed] [Google Scholar]
  25. Keller V. E. Management of nausea and vomiting in children. J Pediatr Nurs. 1995 Oct;10(5):280–286. doi: 10.1016/S0882-5963(05)80045-4. [DOI] [PubMed] [Google Scholar]
  26. Kris M. G., Roila F., De Mulder P. H., Marty M. Delayed emesis following anticancer chemotherapy. Support Care Cancer. 1998 May;6(3):228–232. doi: 10.1007/s005200050158. [DOI] [PubMed] [Google Scholar]
  27. LeBaron S., Zeltzer L. K., LeBaron C., Scott S. E., Zeltzer P. M. Chemotherapy side effects in pediatric oncology patients: drugs, age, and sex as risk factors. Med Pediatr Oncol. 1988;16(4):263–268. doi: 10.1002/mpo.2950160408. [DOI] [PubMed] [Google Scholar]
  28. Marshall G., Kerr S., Vowels M., O'Gorman-Hughes D., White L. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. J Pediatr. 1989 Jul;115(1):156–160. doi: 10.1016/s0022-3476(89)80354-3. [DOI] [PubMed] [Google Scholar]
  29. McQueen K. D., Milton J. D. Multicenter postmarketing surveillance of ondansetron therapy in pediatric patients. Ann Pharmacother. 1994 Jan;28(1):85–92. doi: 10.1177/106002809402800116. [DOI] [PubMed] [Google Scholar]
  30. Mehta P., Gross S., Graham-Pole J., Gardner R. Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children. J Pediatr. 1986 May;108(5 Pt 1):774–776. doi: 10.1016/s0022-3476(86)81066-6. [DOI] [PubMed] [Google Scholar]
  31. Miyajima Y., Numata S., Katayama I., Horibe K. Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol. 1994 Aug;16(3):236–241. doi: 10.1097/00043426-199408000-00009. [DOI] [PubMed] [Google Scholar]
  32. Nahata M. C., Ford C., Ruymann F. B. Pharmacokinetics and safety of prochlorperazine in paediatric patients receiving cancer chemotherapy. J Clin Pharm Ther. 1992 Apr;17(2):121–123. doi: 10.1111/j.1365-2710.1992.tb01279.x. [DOI] [PubMed] [Google Scholar]
  33. Otten J., Hachimi-Idrissi S., Balduck N., Maurus R. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies. Semin Oncol. 1994 Oct;21(5 Suppl 9):17–19. [PubMed] [Google Scholar]
  34. Relling M. V., Mulhern R. K., Fairclough D., Baker D., Pui C. H. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy. J Pediatr. 1993 Nov;123(5):811–816. doi: 10.1016/s0022-3476(05)80866-2. [DOI] [PubMed] [Google Scholar]
  35. Stiakaki E., Savvas S., Lydaki E., Bolonaki I., Kouvidi E., Dimitriou H., Kambourakis A., Kalmanti M. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol. 1999 Mar-Apr;16(2):101–108. doi: 10.1080/088800199277425. [DOI] [PubMed] [Google Scholar]
  36. Tyc V. L., Mulhern R. K., Barclay D. R., Smith B. F., Bieberich A. A. Variables associated with anticipatory nausea and vomiting in pediatric cancer patients receiving ondansetron antiemetic therapy. J Pediatr Psychol. 1997 Feb;22(1):45–58. doi: 10.1093/jpepsy/22.1.45. [DOI] [PubMed] [Google Scholar]
  37. White L., Daly S. A., McKenna C. J., Zhestkova N., Leal C., Breatnach F., Smelhaus V., Hung I. J., Kowalczyk J., Ninane J. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy. Pediatr Hematol Oncol. 2000 Sep;17(6):445–455. doi: 10.1080/08880010050120791. [DOI] [PubMed] [Google Scholar]
  38. Zeltzer L. K., Dolgin M. J., LeBaron S., LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics. 1991 Jul;88(1):34–42. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES